Danpharmacy ApS: Financial statements 2020
CVR: 39361337
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Danpharmacy ApS (CVR 39361337) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -9,225 and a net result of DKK -28,065 compared with DKK 28,044 the year before. Equity in the 2020 report amounted to DKK 44,655. The solvency ratio was 27.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -9,225
- Profit/Loss
- DKK -28,065
- Equity
- DKK 44,655
- Total Assets
- DKK 161,289
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -9 t. | -28 t. | 45 t. | 1 |
| 2019 | - | 37 t. | 28 t. | 73 t. | 1 |
| 2018 | - | 5 t. | -5 t. | 45 t. | 1 |
Official annual report
How creditworthy is Danpharmacy ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Danpharmacy ApS has published its annual report for 2019. Gross profit came to DKK 37,177, and the net result was DKK 28,044.
About Danpharmacy ApS
Danpharmacy ApS was a Danish company of the type Anpartsselskab based in Næstved, founded in 2018. The company has been dissolved on 24 June 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. According to the 2022 annual report, the company had an average of 1 employee. In 2022, the company reported a gross profit of DKK -1,370 and a net result of DKK -19,124 compared with DKK -20,949 the year before. Equity in the 2022 report amounted to DKK 4,583.